CTC Detection - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB506240720

Publication Date:

June 10, 2024

Pages:

111

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

IT Services [2]

Computing & Electronics [3]

Description:

Circulating Tumor Cell (CTC) detection involves identifying and analyzing tumor cells that have detached from a primary tumor and are circulating in the bloodstream. This method can aid in cancer diagnosis and monitoring.
The global market for CTC Detection was estimated to be worth US$ 1246 million in 2023 and is forecast to a readjusted size of US$ 2444.7 million by 2030 with a CAGR of 10.4% during the forecast period 2024-2030
North American market for CTC Detection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for CTC Detection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Europe market for CTC Detection was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global key companies of CTC Detection include Bio-Rad, Roche, Biocartis, Qiagen, Guardant Health, MDxHealth, Johnson & Johnson, NeoGenomics Laboraories and Guangzhou Wondfo Biotech, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for CTC Detection, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of CTC Detection by region & country, by Type, and by Application.
The CTC Detection market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CTC Detection.
Market Segmentation
By Company
Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
Johnson & Johnson
NeoGenomics Laboraories
Guangzhou Wondfo Biotech
TOPGEN
Surexam Bio Tech
Wuhan Yzy Medical Science&Technology
GenoSaber Biotech
BGI Genomics
Segment by Type:
Immunoaffinity Enrichment
Physical Property Enrichment
Other
Segment by Application
Hospital
Third-party Testing Agency
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of CTC Detection manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of CTC Detection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of CTC Detection in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Market Overview
1.1 CTC Detection Product Introduction
1.2 Global CTC Detection Market Size Forecast
1.3 CTC Detection Market Trends & Drivers
1.3.1 CTC Detection Industry Trends
1.3.2 CTC Detection Market Drivers & Opportunity
1.3.3 CTC Detection Market Challenges
1.3.4 CTC Detection Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global CTC Detection Players Revenue Ranking (2023)
2.2 Global CTC Detection Revenue by Company (2019-2024)
2.3 Key Companies CTC Detection Manufacturing Base Distribution and Headquarters
2.4 Key Companies CTC Detection Product Offered
2.5 Key Companies Time to Begin Mass Production of CTC Detection
2.6 CTC Detection Market Competitive Analysis
2.6.1 CTC Detection Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by CTC Detection Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CTC Detection as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Immunoaffinity Enrichment
3.1.2 Physical Property Enrichment
3.1.3 Other
3.2 Global CTC Detection Sales Value by Type
3.2.1 Global CTC Detection Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global CTC Detection Sales Value, by Type (2019-2030)
3.2.3 Global CTC Detection Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Third-party Testing Agency
4.2 Global CTC Detection Sales Value by Application
4.2.1 Global CTC Detection Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global CTC Detection Sales Value, by Application (2019-2030)
4.2.3 Global CTC Detection Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global CTC Detection Sales Value by Region
5.1.1 Global CTC Detection Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global CTC Detection Sales Value by Region (2019-2024)
5.1.3 Global CTC Detection Sales Value by Region (2025-2030)
5.1.4 Global CTC Detection Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America CTC Detection Sales Value, 2019-2030
5.2.2 North America CTC Detection Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe CTC Detection Sales Value, 2019-2030
5.3.2 Europe CTC Detection Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific CTC Detection Sales Value, 2019-2030
5.4.2 Asia Pacific CTC Detection Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America CTC Detection Sales Value, 2019-2030
5.5.2 South America CTC Detection Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa CTC Detection Sales Value, 2019-2030
5.6.2 Middle East & Africa CTC Detection Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions CTC Detection Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions CTC Detection Sales Value
6.3 United States
6.3.1 United States CTC Detection Sales Value, 2019-2030
6.3.2 United States CTC Detection Sales Value by Type (%), 2023 VS 2030
6.3.3 United States CTC Detection Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe CTC Detection Sales Value, 2019-2030
6.4.2 Europe CTC Detection Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe CTC Detection Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China CTC Detection Sales Value, 2019-2030
6.5.2 China CTC Detection Sales Value by Type (%), 2023 VS 2030
6.5.3 China CTC Detection Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan CTC Detection Sales Value, 2019-2030
6.6.2 Japan CTC Detection Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan CTC Detection Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea CTC Detection Sales Value, 2019-2030
6.7.2 South Korea CTC Detection Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea CTC Detection Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia CTC Detection Sales Value, 2019-2030
6.8.2 Southeast Asia CTC Detection Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia CTC Detection Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India CTC Detection Sales Value, 2019-2030
6.9.2 India CTC Detection Sales Value by Type (%), 2023 VS 2030
6.9.3 India CTC Detection Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Bio-Rad
7.1.1 Bio-Rad Profile
7.1.2 Bio-Rad Main Business
7.1.3 Bio-Rad CTC Detection Products, Services and Solutions
7.1.4 Bio-Rad CTC Detection Revenue (US$ Million) & (2019-2024)
7.1.5 Bio-Rad Recent Developments
7.2 Roche
7.2.1 Roche Profile
7.2.2 Roche Main Business
7.2.3 Roche CTC Detection Products, Services and Solutions
7.2.4 Roche CTC Detection Revenue (US$ Million) & (2019-2024)
7.2.5 Roche Recent Developments
7.3 Biocartis
7.3.1 Biocartis Profile
7.3.2 Biocartis Main Business
7.3.3 Biocartis CTC Detection Products, Services and Solutions
7.3.4 Biocartis CTC Detection Revenue (US$ Million) & (2019-2024)
7.3.5 Qiagen Recent Developments
7.4 Qiagen
7.4.1 Qiagen Profile
7.4.2 Qiagen Main Business
7.4.3 Qiagen CTC Detection Products, Services and Solutions
7.4.4 Qiagen CTC Detection Revenue (US$ Million) & (2019-2024)
7.4.5 Qiagen Recent Developments
7.5 Guardant Health
7.5.1 Guardant Health Profile
7.5.2 Guardant Health Main Business
7.5.3 Guardant Health CTC Detection Products, Services and Solutions
7.5.4 Guardant Health CTC Detection Revenue (US$ Million) & (2019-2024)
7.5.5 Guardant Health Recent Developments
7.6 MDxHealth
7.6.1 MDxHealth Profile
7.6.2 MDxHealth Main Business
7.6.3 MDxHealth CTC Detection Products, Services and Solutions
7.6.4 MDxHealth CTC Detection Revenue (US$ Million) & (2019-2024)
7.6.5 MDxHealth Recent Developments
7.7 Johnson & Johnson
7.7.1 Johnson & Johnson Profile
7.7.2 Johnson & Johnson Main Business
7.7.3 Johnson & Johnson CTC Detection Products, Services and Solutions
7.7.4 Johnson & Johnson CTC Detection Revenue (US$ Million) & (2019-2024)
7.7.5 Johnson & Johnson Recent Developments
7.8 NeoGenomics Laboraories
7.8.1 NeoGenomics Laboraories Profile
7.8.2 NeoGenomics Laboraories Main Business
7.8.3 NeoGenomics Laboraories CTC Detection Products, Services and Solutions
7.8.4 NeoGenomics Laboraories CTC Detection Revenue (US$ Million) & (2019-2024)
7.8.5 NeoGenomics Laboraories Recent Developments
7.9 Guangzhou Wondfo Biotech
7.9.1 Guangzhou Wondfo Biotech Profile
7.9.2 Guangzhou Wondfo Biotech Main Business
7.9.3 Guangzhou Wondfo Biotech CTC Detection Products, Services and Solutions
7.9.4 Guangzhou Wondfo Biotech CTC Detection Revenue (US$ Million) & (2019-2024)
7.9.5 Guangzhou Wondfo Biotech Recent Developments
7.10 TOPGEN
7.10.1 TOPGEN Profile
7.10.2 TOPGEN Main Business
7.10.3 TOPGEN CTC Detection Products, Services and Solutions
7.10.4 TOPGEN CTC Detection Revenue (US$ Million) & (2019-2024)
7.10.5 TOPGEN Recent Developments
7.11 Surexam Bio Tech
7.11.1 Surexam Bio Tech Profile
7.11.2 Surexam Bio Tech Main Business
7.11.3 Surexam Bio Tech CTC Detection Products, Services and Solutions
7.11.4 Surexam Bio Tech CTC Detection Revenue (US$ Million) & (2019-2024)
7.11.5 Surexam Bio Tech Recent Developments
7.12 Wuhan Yzy Medical Science&Technology
7.12.1 Wuhan Yzy Medical Science&Technology Profile
7.12.2 Wuhan Yzy Medical Science&Technology Main Business
7.12.3 Wuhan Yzy Medical Science&Technology CTC Detection Products, Services and Solutions
7.12.4 Wuhan Yzy Medical Science&Technology CTC Detection Revenue (US$ Million) & (2019-2024)
7.12.5 Wuhan Yzy Medical Science&Technology Recent Developments
7.13 GenoSaber Biotech
7.13.1 GenoSaber Biotech Profile
7.13.2 GenoSaber Biotech Main Business
7.13.3 GenoSaber Biotech CTC Detection Products, Services and Solutions
7.13.4 GenoSaber Biotech CTC Detection Revenue (US$ Million) & (2019-2024)
7.13.5 GenoSaber Biotech Recent Developments
7.14 BGI Genomics
7.14.1 BGI Genomics Profile
7.14.2 BGI Genomics Main Business
7.14.3 BGI Genomics CTC Detection Products, Services and Solutions
7.14.4 BGI Genomics CTC Detection Revenue (US$ Million) & (2019-2024)
7.14.5 BGI Genomics Recent Developments
8 Industry Chain Analysis
8.1 CTC Detection Industrial Chain
8.2 CTC Detection Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 CTC Detection Sales Model
8.5.2 Sales Channel
8.5.3 CTC Detection Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Bio-Rad
Roche
Biocartis
Qiagen
Guardant Health
MDxHealth
Johnson & Johnson
NeoGenomics Laboraories
Guangzhou Wondfo Biotech
TOPGEN
Surexam Bio Tech
Wuhan Yzy Medical Science&Technology
GenoSaber Biotech
BGI Genomics

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂